Background New-onset seizures are frequently encountered in community and hospital settings. It is likely that seizures presenting in these distinct settings have different etiologies and prognoses, requiring different investigation and treatment approaches. We directly compare the presentation and management of patients with community-and hospital-onset first seizures attending the same hospital.
It is likely that new-onset or newly diagnosed seizures occurring in the community and during hospitalization for nonseizure illnesses have different etiologies and prognoses, thus requiring different investigation and treatment approaches. Previous studies have tended to investigate these cohorts separately, suggesting distinct demographic and treatment patterns. Patients with community-onset seizures (COS) presenting to EDs were reported to be men, in their mid-20s to mid-30s, have generalized convulsions, and be discharged directly home from the ED with almost half prescribed antiepileptic drugs (AEDs). 3, 5 Another study found that patients with hospital-onset seizures (HOS) tended to be men, in their 50s and 60s, have generalized convulsions, and two-thirds were prescribed AEDs at discharge. 6 Direct comparison of patient characteristics between these studies is difficult owing to the different study settings. We compared the clinical presentation and management of COS and HOS within the same hospital.
Methods

Setting
This was a retrospective study of patients managed at Cabrini Malvern Hospital, Melbourne, Australia, between January 1, 2008, and November 30, 2016. The hospital is one of the major general private hospitals in metropolitan Melbourne with a 24/7 ED service. The hospital provides in-and out-patient neurology services including neurophysiology investigations. Medical charts of eligible patients were examined by 2 independent reviewers to extract information on patient demographics and clinical characteristics using a standardized proforma.
Standard protocol approvals, registrations, and patient consents The study was approved by the hospital's Human Research Ethics Committee (study number 02-23-01-17).
Patients
Patients with new-onset or newly recognized seizures were identified by reviewing the medical records of consecutive patients who presented to the hospital's ED (COS group) or had seizures during admission to the inpatient wards for other indications (HOS group), with subsequent discharge International Classification of Diseases, Australian Classification (ICD-10-AM) codes that included G40 (epilepsy), G41 (status epilepticus), and R56.8 (unspecified convulsions). Patients were eligible for inclusion if they were aged 18 years or older, did not have a previous diagnosis of epilepsy, and were not taking AED therapy when the seizure occurred. Patients were excluded if the presenting episode was attributed to an alternative diagnosis, also captured by R56.8, i.e, vasovagal syncope or a psychogenic nonepileptic event.
Definitions
Seizures were classified as provoked (acute symptomatic) 7 or unprovoked 8 according to International League Against Epilepsy (ILAE) guidelines. The former included seizures occurring within 1 week of a brain insult, within 24 hours of severe metabolic derangement, or in the context of excessive alcohol intake or exposure to well-defined proconvulsant drugs. 9, 10 Epilepsy was diagnosed based on the presence of 2 or more unprovoked seizures or 1 seizure with enduring risk of seizure occurrence of >60%. 11 Risk assessment was based on the history of previous brain insult, epileptiform abnormality on EEG, and epileptogenic lesion identified on brain imaging 12 (appendix e-1, links.lww.com/CPJ/A51). Epilepsy syndromes and seizure types were classified according to the latest ILAE schemes. 13, 14 Data availability Anonymized data, and the standardized proforma used to extract information on patient demographics and clinical characteristics, will be shared by request from any qualified investigator.
Statistical analysis
The Fisher exact test was performed to compare categorical variables. The Mann-Whitney U test was used to compare continuous variables. Odds ratios (ORs) for diagnostic results and commencement of AED therapy in the 2 groups were calculated. All statistical tests were performed by using Stata14 (StataCorp, College Station, TX). Statistical significance level of 0.05 was used unless otherwise specified. Bonferroni correction was applied for multiple testing.
Results
Patient characteristics
A total of 367 patients were discharged with one of the relevant ICD-10-AM codes. Among them, 151 patients met the inclusion criteria as having had new-onset or newly recognized seizures. Their median age was 74 years (interquartile range [IQR] 55-83 years). Fifty-two patients were aged <65 years (40 in the HOS group and 12 in the COS group). Eighty-four (55.6%) were women. The remaining 216 were excluded: 186 had a preexisting epilepsy diagnosis and 30 had nonseizure final diagnoses (figure 1). Gastric disease (peptic ulcer disease and liver condition)
Abbreviations: COS = community-onset seizures; HOS = hospital-onset seizures; IQR = interquartile range. a After Bonferroni correction, statistical significance of p value = 0.0167 was used for age, sex, and any medical illness; p value = 0.01 was used for the 5 medical illness subcategories.
95% confidence interval [CI] 4.45-62.4, p < 0.001), most commonly the perioperative use of tranexamic acid ( 
Discussion
This study reveals clear differences in characteristics between patients presenting after new-onset seizures occurring in the community and those that occurred during hospitalization for non-seizure-related illnesses. The latter group were older and more likely to have acute symptomatic seizures, whereas those with COS were more likely to be diagnosed with newonset epilepsy, yet a similar proportion of patients in each group were prescribed AED therapy on discharge.
As noted in previous studies, the HOS group was significantly older than the COS group. A provoking etiology was identified in over half the HOS group, with exposure to proconvulsant drugs, most commonly tranexamic acid, the major causative drug. The rate of provoked seizures in the HOS group was higher (63.0%) than the 20%-50% previously
Although guidelines provide general recommendations, ultimately the risks and benefits of initiating AED therapy need to be tailored to the individual patient. Abbreviations: BL TCS = bilateral tonic clonic seizure; COS = community-onset seizures; FAS = focal aware seizure; FIAS = focal impaired awareness seizure; GTCS = generalized tonic-clonic seizure; HOS = hospital-onset seizures; ILAE = International League Against Epilepsy. a After Bonferroni correction, statistical significance of p value = 0.0071 was used for the 7 main seizure characteristics and investigations, p value = 0.0056 was used for 9 subcategories of acute symptomatic seizure risk factors, p value = 0.0083 for 6 subcategories of remote seizure etiologies, p value = 0.025 for 2 subcategories of CSF analysis, and p value = 0.0167 for 3 subcategories of ILAE diagnosis.
reported. 15, 16 This may reflect lower seizure thresholds in an older, hospitalized patient population that has increased susceptibility to acute brain insults. The association between tranexamic acid and an increased incidence of seizures, particularly during the early postoperative period after cardiac surgery, is well described. 17 This was strongly supported in our study, with 27.8% of the HOS group having received tranexamic acid in the period around cardiac surgery. Strategies to reduce the risk of tranexamic acid-associated seizures should be considered, including the use of reduced dosage and continuing the general anesthetic agent for several hours after a surgical procedure, if safe and practicable to do so. 10 In contrast, the majority of the COS group had no identifiable acute provoking factors but had higher rates of remote seizure risk factors. The most commonly identified remote seizure risk factor was cerebral lesions, including structural brain damage from ischemic strokes, and primary and metastatic cerebral cancers. This is consistent with findings from a study that reported stroke and tumors as the underlying seizure etiology for 23% and 9% of patients hospitalized with firstever seizures, respectively. 6 Hauser et al. 18 reported that the highest incidence of epilepsy occurred in people older than 75 years. This may explain the high rates of new epilepsy diagnosis in our elderly cohort with almost three-fifths of COS and one-fifth of HOS groups fulfilling the ILAE diagnostic criteria. The decision to initiate AED therapy is complex and needs to consider patient preference, medical comorbidities, concomitant medications, and specific epilepsy syndrome or presenting seizure type(s).
19-21 AED therapy is generally recommended for those with an enduring propensity for further seizures (i.e., fulfilling the ILAE diagnostic criteria). Conversely, AED therapy is not indicated in those with acute symptomatic seizures, which have a low risk of recurrence. 22 AED therapy was initiated in over four-fifths of patients with newly diagnosed epilepsy. Similar prescribing patterns were noted in a Swedish population-based registry: 85.1% of patients with newly diagnosed epilepsy were prescribed AED therapy within the first year after the index seizure. 23 Conversely, 65% of COS and 80% of HOS patients without newly diagnosed epilepsy were also prescribed AED therapy. The decision to prescribe or not to prescribe requires careful balancing of the risk of missed opportunities for initiation and titration of appropriate therapy against the risk of overtreatment with potential side effects and drug-drug interaction. This study highlights the complexity of clinical practice: although guidelines provide general recommendations, ultimately the risks and benefits of initiating AED therapy need to be tailored to the individual patient.
Phenytoin was the commonest AED monotherapy prescribed at discharge. This prescribing behavior is consistent with previous US-based studies regarding seizure presentations to EDs 3 and occurring in hospital. 6 However, it differs from the Swedish population registry that reported carbamazepine as the most frequent initially prescribed AED. 23 The difference may reflect local prescribing habit. Phenytoin has many drug-drug interactions, a considerable side effect profile including the increased risk of osteoporosis and Stevens-Johnson syndrome, and requires regular blood tests to monitor drug levels and screen for organotoxicity. 20, 22 In this regard, phenytoin might not have been the most appropriate initial AED for our elderly study population, many of whom had comorbidities and were taking polypharmacy.
Patients in our study were older than those in other studies reporting on COS and HOS. This may reflect the older population in the hospital catchment area. 24 The majority of COS presenting to the ED were admitted to the ward. This is in keeping with previous Australian research 5 that reported increased rates of seizure-related hospitalizations for patients aged >65 years, likely because of comorbidities occurring more frequently in the elderly, such as stroke and cancer.
Although the majority of new-onset seizures in the elderly are focal, 25 convulsive seizures were the most frequent presentation in both the COS and HOS groups. Our results are consistent with previous work demonstrating that first seizures are twice as likely to be generalized than focal. 2 One study reported that 86% of COS presenting to the ED were generalized convulsions 3 ; another study found that generalized seizures were the commonest type in an HOS group. 6 This bias toward generalized seizures might be because focal seizures are not readily brought to medical attention, as they are either not detected or not of sufficient concern to patients or bystanders. Conversely, generalized, convulsive seizures are more alarming and may prompt bystanders to rapidly involve emergency services.
Limitations
Limitations of this survey include its small study size, which reduces its power to determine ability for some tests, such as CSF analysis, to detect abnormalities. Long-term follow-up data, including data from other health services, were not readily available. Efforts were made to minimize the effect on the validity of findings by reviewing all information within medical records including medical, nursing, and allied health notes; reviewing each patient's entire medical record from index seizure event through to most recent hospital episode; and review of correspondence from other health services. The retrospective nature of this survey carries inherent uncertainty with regard to exact diagnosis. However, a previous study found that external review of medical records has high specificity and sensitivity for diagnosis and determination of activity for new-onset seizure and new-onset epilepsy. 26 Diagnosis of any disease is based on contemporary guidelines. In 2014, the ILAE expanded epilepsy diagnostic criteria. Applying these updated diagnostic criteria to patients assessed before 2014 might have resulted in reclassification of more cases as newly diagnosed epilepsy. It is acknowledged that the bias toward older age and a private hospital setting may limit the generalizability of the results. However, those aged >65 years are most likely to develop new-onset seizures in high-income countries. This study therefore provides valuable insights into this specific demographic and hospital setting. Information regarding the duration of AED therapy was not available, and prescription at discharge, especially for those with provoked seizures, may have been short-term therapy to cover an "at-risk" period. EEG rates were less than expected. We speculate that EEG might have been omitted because of lack of availability outside business hours, for patients with obvious acute symptomatic seizures, and for extremely frail patients nearing palliation, on the basis that results would be low yield or not change overall prognosis and management.
Conclusion
Elderly hospitalized patients are at an increased risk of provoked seizures. Due care should be exercised when prescribing potentially proconvulsant medications for this group. We highlight particularly the seizure risks associated with tranexamic acid, especially in the context of cardiac surgery. AED prescription decisions at discharge revealed the complexities of clinical practice, with factors beyond newdiagnosis epilepsy likely influencing decisions regarding AED initiation. Further study is needed into patient and seizure characteristics for new-onset or newly recognized seizures that occur in the community compared with those that occur in patients already hospitalized for nonseizure illnesses to help guide hospital policies and ensure the appropriate use of hospital and community health resources. Further studies should also consider morbidity, mortality, and health economic effects of first seizures and assess optimal management to improve outcomes in this cohort.
Author contributions E. Foster: conception of the manuscript, collection of data, preparation of the manuscript, and critical revision of the manuscript for intellectual content. S. Holper: collection of data and critical revision of the manuscript for intellectual content. Z. Chen: statistical analysis. P. Kwan: conception of the manuscript and critical revision of the manuscript for intellectual content.
Study funding
No targeted funding reported.
